Portelinha, Ana http://orcid.org/0000-0003-0518-9554
da Silva Ferreira, Mariana
Erazo, Tatiana
Jiang, Man
Asgari, Zahra
de Stanchina, Elisa
Younes, Anas http://orcid.org/0000-0002-0001-4133
Wendel, Hans-Guido http://orcid.org/0000-0001-7166-4670
Funding for this research was provided by:
Foundation for the National Institutes of Health (P50 CA217694)
Memorial Sloan-Kettering Cancer Center (P30 CA008748)
Lymphoma Research Foundation
Geoffrey Beene Cancer Research Center
Article History
Received: 2 December 2021
Accepted: 7 March 2023
First Online: 18 March 2023
Competing interests
: A.Y. is currently employed by AstraZeneca. The remaining authors declare no competing interests.